(NU/1868) The Provision of DNA Genotyping and Methylation Services in Developmental and Aged Musculoskeletal Tissues

Newcastle UniversitycontractContracts FinderRef NCL001-DN652992-66897254SME suitablecomplete
View buyer

Estimated value

£100k

Awarded value

£91k

Awarded 09 Mar 2023

Suppliers

1

Lots

1

1 awarded

Published

23 Mar 2023

Deadline 16 Feb 2023

Description

The Newcastle University Biosciences Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including this investigation into genetic influences upon DNA methylation during development, ageing and disease of the human hip. This project funded by Versus Arthritis aims to investigate how a transcription factor (RUNX2) is regulated epigenetically in development and in later life, contributing to a range of traits and diseases including height, hip shape, facial morphology, osteoarthritis, and osteoporosis. The purpose of this tender process is to engage a supplier to run Illumina MethylationEPIC and Infinium Global Screening Arrays to generate both DNA methylation and genotype data on 360 supplied DNA samples.

Scope

Reference
NCL001-DN652992-66897254
Total value
£100,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
10 Mar 2023 to 21 Aug 2023
CPV classifications
73111000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
16 Feb 2023, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£91k

Award date

09 Mar 2023

Contract start

10 Mar 2023

Contract end

21 Aug 2023